Cargando…

Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma

Analysis of single-cell RNA sequencing (scRNA-seq) data of immune cells from the tumor microenvironment (TME) may identify tumor progression biomarkers. This study was designed to investigate the prognostic value of differentially expressed genes (DEGs) in intrahepatic cholangiocarcinoma (ICC) using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Miao, Qiao, Kuang-Yuan, Xie, Xiao-Li, Zhu, Xin-Ying, Gao, Fu-Lai, Li, Chang-Juan, Zhao, Dong-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890365/ https://www.ncbi.nlm.nih.gov/pubmed/33613623 http://dx.doi.org/10.3389/fgene.2020.615680

Ejemplares similares

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022)

Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing
por: Bian, Jing, et al.
Publicado: (2022)

CEACAM6 gene expression in intrahepatic cholangiocarcinoma
por: Ieta, K, et al.
Publicado: (2006)

Characterization and prognostic significance of mortalin, Bcl-2 and Bax in intrahepatic cholangiocarcinoma
por: Kang, Qiang, et al.
Publicado: (2018)

Systemic Analysis on the Features of Immune Microenvironment Related to Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Su, Kaixin, et al.
Publicado: (2022)

Exploring the role of tumor stemness and the potential of stemness-related risk model in the prognosis of intrahepatic cholangiocarcinoma
por: Yue, Yuan, et al.
Publicado: (2023)

The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Chen, Liwei, et al.
Publicado: (2023)

A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma
por: Zou, Wenbo, et al.
Publicado: (2021)

Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type
por: Shiao, Meng-Shin, et al.
Publicado: (2018)

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
por: Zhang, Rui, et al.
Publicado: (2021)

Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma
por: DHANASEKARAN, RENUMATHY, et al.
Publicado: (2013)

A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma
por: Yu, Hua, et al.
Publicado: (2020)

A gene signature is critical for intrahepatic cholangiocarcinoma stem cell self-renewal and chemotherapeutic response
por: Huang, Lifeng, et al.
Publicado: (2022)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Integrated single-cell and bulk RNA sequencing analyses reveal a prognostic signature of cancer-associated fibroblasts in head and neck squamous cell carcinoma
por: Yang, Yichen, et al.
Publicado: (2022)

NRP1 is a Prognostic Factor and Promotes the Growth and Migration of Cells in Intrahepatic Cholangiocarcinoma
por: Wu, Yong-Na, et al.
Publicado: (2020)

Integrating cell interaction with transcription factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinoma
por: Wang, Tingjie, et al.
Publicado: (2022)

Deciphering the Pyroptosis-Related Prognostic Signature and Immune Cell Infiltration Characteristics of Colon Cancer
por: Wei, Ran, et al.
Publicado: (2021)

Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma
por: Zhou, Xianghong, et al.
Publicado: (2020)

Development of an Immune-Related Prognostic Signature in Breast Cancer
por: Xie, Peiling, et al.
Publicado: (2020)

DWI-based radiomic signature: potential role for individualized adjuvant chemotherapy in intrahepatic cholangiocarcinoma after partial hepatectomy
por: Yang, Yang, et al.
Publicado: (2022)

Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma
por: Zhang, Chi, et al.
Publicado: (2013)

Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Burkhart, Richard A., et al.
Publicado: (2017)

Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma
por: Seo, Jung Woong, et al.
Publicado: (2020)

Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival
por: Thakral, Nimish, et al.
Publicado: (2023)

Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma
por: Chai, Xiu-kun, et al.
Publicado: (2021)

Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection
por: Jeong, Seogsong, et al.
Publicado: (2017)

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma
por: Song, Guohe, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Prognostic analysis of m6A-related lncRNAs as potential biomarkers in intrahepatic cholangiocarcinom
por: Shi, Guodong, et al.
Publicado: (2022)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma
por: Zhang, Lilong, et al.
Publicado: (2023)

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
por: Zhou, Kangjie, et al.
Publicado: (2022)

Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma
por: Xu, Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1658do8v99t31c4qfqfnql1uog